Earnings Preview For Travere Therapeutics
Portfolio Pulse from Benzinga Insights
Travere Therapeutics (NASDAQ:TVTX) is scheduled to release its quarterly earnings report on February 15, 2024, with an expected EPS of $-1.26. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for future growth. Historical data shows mixed reactions to past earnings, with stock performance varying. Currently, shares are trading at $7.99, reflecting a 59.46% decrease over the last 52 weeks, indicating long-term shareholder dissatisfaction.
February 14, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Travere Therapeutics is expected to report an EPS of $-1.26 for the upcoming quarter, with investors hoping for a beat and positive future guidance.
The expected EPS of $-1.26 sets a clear benchmark for Travere Therapeutics' performance. Historical data shows that the company's stock price can react variably to earnings reports and guidance. Given the current trading price and the significant decrease over the past year, the upcoming earnings report could either help to stabilize the stock price or lead to further declines, depending on whether the company meets or exceeds expectations and provides positive guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100